Stay updated on Nivolumab vs Sorafenib in Advanced Hepatocellular Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab vs Sorafenib in Advanced Hepatocellular Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab vs Sorafenib in Advanced Hepatocellular Carcinoma Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Revision: v3.4.3 was added and Revision: v3.4.2 was removed.
    Difference
    0.0%
    Check dated 2026-03-12T21:33:36.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    35 days ago
    Change Detected
    Summary
    Site revision updated from v3.4.1 to v3.4.2. No visible content or functionality changes were observed.
    Difference
    0.0%
    Check dated 2026-02-12T02:25:46.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Site revision updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-04T23:43:24.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    UI and metadata updates: a Show glossary option was added and the QC update label capitalization was adjusted (Last Update Submitted that Met QC Criteria added; the lowercase variant removed). Footer-related changes include updating No FEAR Act data references and revision/version information (Revision: v3.4.0 added and Revision: v3.3.4 removed).
    Difference
    0.1%
    Check dated 2026-01-28T21:47:58.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    The page shows a minor metadata change: Revision: v3.3.4 was added and Revision: v3.3.3 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-14T04:08:59.000Z thumbnail image
  8. Check
    85 days ago
    Change Detected
    Summary
    Added a comprehensive Locations section listing study sites across multiple countries and regions (e.g., United States states such as Alabama, California, Illinois, Louisiana, New York, North Carolina, Pennsylvania, Texas, Washington; Australia, Canada, China, Japan, United Kingdom, and more).
    Difference
    2%
    Check dated 2025-12-23T21:39:21.000Z thumbnail image

Stay in the know with updates to Nivolumab vs Sorafenib in Advanced Hepatocellular Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab vs Sorafenib in Advanced Hepatocellular Carcinoma Clinical Trial page.